Amp Capital Investors LTD Moderna, Inc. Transaction History

Amp Capital Investors LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $21.5 Million - $35.2 Million	-95,398 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $6.5 Million - $14.2 Million	-29,308 Reduced 23.5%	95,398 $36.7 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $2.52 Million - $4.57 Million	19,434 Added 18.46%	124,706 $29.3 Million
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $2.5 Million - $4.26 Million	22,910 Added 27.82%	105,272 $13.6 Million
Q4 2020 Feb 12, 2021	BUY	$65.74 - $169.86 $1.05 Million - $2.72 Million	16,002 Added 24.11%	82,362 $9.15 Million
Q3 2020 Nov 12, 2020	BUY	$54.34 - $94.85 $399,399 - $697,147	7,350 Added 12.46%	66,360 $4.68 Million
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $1.75 Million - $4.72 Million	59,010 New	59,010 $3.66 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

Stay updated on Amp Capital Investors LTD with notifications on news.